Buprenorphine-induced acute respiratory depression during ifosfamide-based chemotherapy [3]

Annals of Oncology

Volumn 17, Issue 9, 2006, Pages 1466-1467

  Moro, Cecilia ^a   Taino, R ^a   Mandala M ^a   Labianca, R ^a  

^a OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CISPLATIN; CODEINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PARACETAMOL;

ACUTE DISEASE; ADULT; ANALGESIA; BONE RESECTION; BRADYPNEA; CANCER COMBINATION CHEMOTHERAPY; CANCER PAIN; CASE REPORT; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG POTENTIATION; HOSPITAL ADMISSION; HUMAN; LETTER; MALE; OSTEOSARCOMA; PELVIS CANCER; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SINUS BRADYCARDIA;

ACUTE DISEASE; ADULT; ANALGESICS, OPIOID; ANTINEOPLASTIC AGENTS, ALKYLATING; BUPRENORPHINE; HUMANS; IFOSFAMIDE; MALE; OSTEOSARCOMA; PAIN; PELVIC NEOPLASMS; RESPIRATORY INSUFFICIENCY; SKULL NEOPLASMS;

EID: 33748748215     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl059     Document Type: Letter

References (5)

1. Terlinden R, Stadler T. Pharmacokinetic study on single application of buprenorphine transdermal study (TDS). Aachen: Grunthal GmbH 2000.
2. Sittl R, Griessinger N. Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadeguately controlled chronic pain related to cancer and other disorders: A multicenter randomized double-blind, placebo controlled trial. Clin Ther 2003; 25: 150-168.
3. Furlanut M, Franceschi L. Pharmacology of ifosfamide. Oncology 2003; 65 (Suppl 2): 2-6.
4. Dahan A, Yassen A. Comparison of the respiratory effects of intravenous bupronorphine and fentanyl in humans and rats. Br J Anesth 2005; 94: 825-834.
5. Hamunen K, Olkkola KT. Comparison of the ventilatory effect of morphine and buprenorphine in children. Acta Anaesthesiol Scan 1993; 37: 499-453.